Detail
| LncRNA Name | BCAR4 |
| Synonyms | NA |
| Region | GRCh38_16:11819829-11828845 Sequence |
| Ensembl | ENSG00000262117 |
| RefSeq | NR_024049 |
| Circulating | ✘ |
| Drug-resisitant | ✘ |
| Prognostic | ✔ |
| MiRNA | ✘ |
| Variant | ✘ |
| TF | ✘ |
| Methylation | ✘ |
| Cancer Name | cervical cancer |
| ICD-0-3 | C53 |
| Methods | qPCR, Western blot, etc. |
| Sample | cervical cancer tissues, cell lines (HeLa, SiHa, Caski, C4-1, C-33A) |
| Expression Pattern | up-regulated |
| Function Description | patients with high BCAR4 expression showed worse survival outcomes and overexpression of BCAR4 might be an independent prognostic factor in cervical cancer. |
| Pubmed ID | 29937186 |
| Year | 2018 |
| Title | Up-regulated BCAR4 contributes to proliferation and migration of cervical cancer cells.overexpression of BCAR4 promoted epithelial-mesenchymal transition (EMT) process and silencing BCAR4 suppressed EMT process in cervical cancer cells. |
| External Links |
| Links for BCAR4 | GenBank HGNC lncrnadb Noncode |
| Links for cervical cancer | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.